Clinical Trials Browser

Enrolling by invitation × Cisplatin × Clear all

NCT07139951 2025-12-31

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence

Phase 2 Enrolling by invitation

Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

NCT07312578 2025-12-31

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

Phase 2 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06755515 2025-01-01

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Phase 2/3 Enrolling by invitation

Uterine Cervical Neoplasms

NCT06048926 2023-09-21

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

Phase NA Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04762459 2022-02-24

APEX

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung